Skip to main content
Human Vaccines & Immunotherapeutics logoLink to Human Vaccines & Immunotherapeutics
letter
. 2013 Apr 5;9(6):1325. doi: 10.4161/hv.24087

Reply Letter

Carmen Baccarini 1,*, Andrew Ternouth 2, Heather Wieffer 2, Andrew Vyse 3
PMCID: PMC3901825  PMID: 23563056

Dear Editors,

We thank Dr. Bettinger et al.1 for the clarification, and for providing valuable updates on the current epidemiology and surveillance of meningococcal disease in Canada. The objective of our review was to provide an overview of the epidemiology of meningococcal disease in North America during the last half century and portray how it has evolved over time, particularly in response to the different vaccination strategies employed by the US and Canada, rather than focus on the contemporary situation in each country.

Bettinger Julie A, Scheifele David W, Halperin Scott A, Vaudry Wendy, Le Saux Nicole. Response to the changing epidemiology of meningococcal disease in North America 1945â��2010. vaccines. 2013;9:1323–1324. doi: 10.4161/hv.24009.

Footnotes

Reference

  • 1.Bettinger JA, Scheifele DW, Halperin SA, Vaudry W, Le Saux N. The changing epidemiology of meningococcal disease in North America 1945–2010. Hum Vaccin Immunother. 2013;9 doi: 10.4161/hv.24009. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Human Vaccines & Immunotherapeutics are provided here courtesy of Taylor & Francis

RESOURCES